Current Value of Holding

$68.9 Million

Shares

162 Thousand

% of Portfolio

0.07%

Average Buy Price

$366

Avg closing price
Price range

45 Ken Griffin Vertex Pharmaceuticals Trades

Ken Griffin acquired 172 Thousand Vertex Pharmaceuticals shares worth $73 Million. That's 0.07% of their equity portfolio (351st largest holding). The first Vertex Pharmaceuticals trade was made in Q3 2013. Since then Ken Griffin bought shares 54 more times and sold shares on 56 occasions. The stake costed the investor $38.5 Million, netting the investor a gain of 89% so far.

Avg closing price
Price range
Increased shares by 222.9% (+112 Thousand shares) Q4 2024
Avg closing price $461.09
Price range $397.27 - $516.74
Sold 52.0% shares (-54.4 Thousand shares) Q3 2024
Avg closing price $480.45
Price range $460.00 - $505.78
Increased shares by 27.6% (+22.6 Thousand shares) Q2 2024
Avg closing price $434.05
Price range $392.81 - $485.53
Sold 74.9% shares (-245 Thousand shares) Q1 2024
Avg closing price $422.74
Price range $407.69 - $446.08
Increased shares by 1077.5% (+299 Thousand shares) Q4 2023
Avg closing price $369.42
Price range $343.00 - $410.68
Increased shares by 24452.2% (+27.6 Thousand shares) Q3 2023
Avg closing price $349.73
Price range $338.18 - $362.46
Sold 99.9% shares (-83.7 Thousand shares) Q2 2023
Avg closing price $336.94
Price range $314.42 - $351.91
Sold 58.8% shares (-120 Thousand shares) Q1 2023
Avg closing price $299.93
Price range $283.23 - $323.10
Increased shares by 1379.2% (+190 Thousand shares) Q4 2022
Avg closing price $304.77
Price range $285.76 - $321.48
New holding (+13.8 Thousand shares) Q3 2022
Avg closing price $287.72
Price range $273.83 - $305.53
Sold -42.6 Thousand shares Q2 2022
Avg closing price $267.66
Price range $234.96 - $292.55
Sold 83.1% shares (-210 Thousand shares) Q1 2022
Avg closing price $237.33
Price range $221.42 - $260.97
Sold 39.0% shares (-162 Thousand shares) Q4 2021
Avg closing price $194.45
Price range $177.01 - $223.45
Increased shares by 6.3% (+24.5 Thousand shares) Q3 2021
Avg closing price $195.24
Price range $181.39 - $202.99
Sold 77.3% shares (-1.33 Million shares) Q2 2021
Avg closing price $209.17
Price range $187.49 - $221.10
Increased shares by 88.5% (+807 Thousand shares) Q1 2021
Avg closing price $219.65
Price range $207.02 - $241.31
New holding (+912 Thousand shares) Q3 2020
Avg closing price $275.88
Price range $255.65 - $303.10
Sold -447 Thousand shares Q2 2020
Avg closing price $271.12
Price range $225.48 - $295.80
Sold 56.6% shares (-584 Thousand shares) Q1 2020
Avg closing price $229.39
Price range $199.77 - $247.81
Increased shares by 44.2% (+316 Thousand shares) Q4 2019
Avg closing price $202.38
Price range $166.71 - $223.91

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!